Insilico Medicine - Olean Times Herald

Press Releases

Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation

Insilico Medicine

March 13, 2025

CAMBRIDGE, Mass. , March 13, 2025 /PRNewswire/ -- Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug ...

Press Releases

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

Insilico Medicine

January 10, 2025

FLORENCE, Italy and CAMBRIDGE, Mass. , Jan. 10, 2025 /PRNewswire/ -- TheMenarini Group ("Menarini"), a leading international pharmaceutical and diagno...

Press Releases

Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease

Insilico Medicine

January 7, 2025

CAMBRIDGE, Mass. , Jan. 7, 2025 /PRNewswire/ -- Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug d...

Press Releases

Nature Biotechnology | Generative Chemistry Enables Insilico to Develop Gut-Restricted PHD Inhibitors Promising for Intestinal Mucosal Barrier Repair and Immunomodulation

Insilico Medicine

December 11, 2024

CAMBRIDGE, Mass. , Dec. 11, 2024 /PRNewswire/ -- Inflammatory bowel disease (IBD), consisting primarily of ulcerative colitis and Crohn's disease, is ...

Press Releases

Insilico Medicine Announces Positive Topline Results of ISM001-055 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Developed Using Generative AI

Insilico Medicine

November 12, 2024

Highlights: CAMBRIDGE, Mass. , Nov. 12, 2024 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-...

Olean Times Herald

Get in touch with Olean Times Herald

Submit Content

Advertise

Subscribe